Drug Shortage Report for BURINEX
Report ID | 226761 |
Drug Identification Number | 00728284 |
Brand name | BURINEX |
Common or Proper name | BURINEX |
Company Name | KARO PHARMA AB |
Market Status | MARKETED |
Active Ingredient(s) | BUMETANIDE |
Strength(s) | 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | C03CA |
ATC description | HIGH-CEILING DIURETICS |
Reason for shortage | Shortage of an active ingredient. |
Anticipated start date | 2024-03-14 |
Actual start date | |
Estimated end date | 2024-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | KLARA NORRA KYRKOGATA 33 STOCKHOLM, -- SWEDEN 11122 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-05-01 | French | Compare |
v2 | 2024-05-01 | English | Compare |
v1 | 2024-05-01 | English | Compare |
Showing 1 to 3 of 3